Press Release: Syntec Optics' (Nasdaq: OPTX) Q3 Hits All Time High Revenue, Profits Grow to Double-Digit Adj Ebitda, and Net Income Surges Positive

Dow Jones11-14

ROCHESTER, NEW YORK, Nov. 13, 2026 (GLOBE NEWSWIRE) -- Syntec Optics Holdings, Inc. (Nasdaq: OPTX) ("Syntec Optics" or the "Company"), a provider of deep-tech products to industry pioneers connecting and protecting the world, today announced financial results for the third quarter ended September 30, 2026. Supporting mission-critical applications ranging from low-Earth-orbit satellites and bipartisan connected-battlefield defense platforms to life sciences, Syntec delivered an all-time high revenue of $8.5 million, up 23% year over year, and net income improved by $1.6 million to a positive net income of $0.2 million, compared with a $1.4 million net loss in the prior-year quarter. The quarter's results reflect Syntec's expanding role in next-generation bipartisan defense and space technologies, including continued growth in major programs of national importance like Artemis III, low-Earth orbit reconnaissance, satellite collision-avoidance, and AR/VR soldier gear. Syntec combined these achievements with lower selling, general, and administrative expenses. Overall cash reserves strengthened, growing by $0.3 million.

Earnings Call information:

Date: Tuesday, November 17, 2026

Time: 5:00 p.m. ET

Register in Advance (Required): https://us06web.zoom.us/meeting/register/wUCh5icdSQm20ccy7aOSoA

(After registering, you will receive a confirmation email containing information about joining the meeting.)

Webcast: A recording of the conference call will be available under the Latest Events section on the Investors page of Syntec Optics' website at www.syntecoptics.com.

Replay: A replay of the webcast will be available approximately three hours after the call concludes. It will remain accessible until Tuesday, December 1, 2026, in the Investor Relations section of Syntec Optics' website at www.syntecoptics.com.

"We are excited to be moving quickly with a well-disciplined execution plan, adding proven pioneering programs to existing customer products, all typical with a 7-10 year product life cycle and needing replacement over time," said Matt Carey, Vice President of Business Development.

Gross profit for the quarter increased 127% year over year to $1.9 million. Gross margin nearly doubled compared with the prior-year quarter. Selling, general, and administrative expenses were $1.7 million, reduced by $0.3 million from the prior-year quarter. Adjusted EBITDA was $0.9 million, or 10% of revenue, compared with approximately break-even and an Adjusted EBITDA margin of nearly 0% in the prior-year quarter.

Beginning this quarter, we are presenting revenue across five end markets: Space Tech, Defense Tech, Life Sciences, AI Data Center, and Other Scientific Instruments. These categories will provide greater visibility into the markets served by our products and the demand drivers affecting our business going forward. Space Tech includes space-related communications, orbital safety, reconnaissance, and rockets. Defense Tech covers bipartisan, cross-administration, proven next-gen AI-driven AR/VR connected battlefield, night-vision, and other soldier gear. Together, Space Tech and Defense Tech represent 64% of our third-quarter revenues and are expected to continue driving our success in subsequent quarters.

Our fastest-growing end market is space technology. Syntec is excited to share that Space Tech revenue increased 117% year over year to $1.3 million. In Q3, Space Tech represented 15% of quarterly revenue and was the fastest-growing segment for the quarter. Our space products support low-Earth-orbiting satellites, debris detection and collision avoidance, reconnaissance, and lunar rocket hardware. In Q3, we announced orders that expand our participation in orbital safety and government satellite reconnaissance. These new product lines broaden our space business across multiple customer programs and mission requirements.

After quarter-end, we announced orders for a new program for our actuator products to support NASA's Artemis III rockets. This program extends our space portfolio from satellites into hardware supporting lunar missions.

Defense Tech revenues increased 31% year over year to $4.2 million. This represents 49% of quarterly revenue. Our products support AI-enabled AR/VR soldier systems, night vision, missile guidance, and laser targeting products. Announcements during the year included camera and display-window products for military wearable systems, demonstrating expanded participation in customer platforms. Growth across established and newer applications supports our focus on supplying mission-critical products throughout customer program life cycles.

Our Life Sciences revenue increased 12% year over year to $2.7 million, representing 31% of quarterly revenue. Our product lines in this market serve blood diagnostics for early detection of disease, biomedical illumination and visualization, surgical robotics, DNA sequencing, ophthalmology, and veterinary care. These programs provide a substantial revenue base alongside our expanding defense and space base, giving Syntec a more diverse product mix.

AI Data Center revenue was $0.2 million. We expect this category to grow in the coming years as our products are deployed across multiple value chains within the data center. Activities include precision micro-connectors for transceivers and photonic integrated circuits, as well as optics supporting emerging orbital and earth-based fusion energy. A massive energy shortage is predicted by nearly all analysts, and Syntec plans to participate in next-generation products with cutting-edge pioneers. In August, we reported approximately $4.0 million in cumulative orders across the broader AI infrastructure "picks and shovels" opportunity since entering that market roughly two years ago.

Other scientific instruments revenue, which includes products for quantum computing applications, was $0.2 million.

The Company ended the quarter with $14.4 million in cash and cash equivalents, up from $14.0 million at the end of the second quarter. Operating activities generated $1.3 million of cash during the first nine months of the year. "Our strong cash position gives us the flexibility to invest alongside our customers as their next-generation technologies ramp up to high production volumes for 7-10 year product life cycles," said Dean Rudy, Chief Financial Officer. "We see an opportunity to build on our momentum in defense and space by expanding our manufacturing capabilities, utilizing our open capacity, and pursuing complementary growth opportunities. Our focus is on translating that opportunity into sustained revenue growth and stronger profitability."

In the fourth quarter and beyond, the company continues to add new programs to utilize our open capacity for long product life cycles.

About Syntec Optics

Headquartered in Rochester, N.Y., Syntec Optics Holdings, Inc. (NASDAQ: OPTX) is one of the nation's largest bespoke makers of high-precision optics. It pushes the limits of light-based technologies to connect and protect the world. Syntec supports critical missions ranging from low-Earth-orbit satellites to advanced next-gen connected-battlefield defense platforms, moon rocket actuators, AI data centers, and life sciences. As light-enabled technologies continue to account for a significant portion of global economic output--representing nearly $20 trillion of the $111 trillion in total worldwide production as of 2024--Syntec Optics remains positioned at the forefront of the modern optical revolution.

For more information, visit syntecoptics.com.

Forward-Looking Statements

This press release contains certain "forward-looking statements" within the meaning of the United States Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended (the "Securities Act") and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical fact contained in this press release, including statements as to the intended use of net proceeds from the public offering, are forward-looking statements. Some of these forward-looking statements can be identified by the use of forward-looking words, including "may," "should," "expect," "intend," "will," "estimate," "anticipate," "believe, " "predict," "plan," "targets," "projects," "could," "would," "continue, " "forecast" or the negatives of these terms or variations of them or similar expressions. All forward-looking statements are subject to risks, uncertainties, and other factors (some of which are beyond the control of Syntec Optics), which could cause actual results to differ materially from those expressed or implied by such forward-looking statements. All forward-looking statements are based upon estimates, forecasts and assumptions that, while considered reasonable by Syntec Optics and its management, as the case may be, are inherently uncertain and many factors may cause the actual results to differ materially from current expectations which include, but are not limited to: 1) risk outlined in any prior SEC filings; 2) ability of Syntec Optics to successfully increase market penetration into its target markets; 3) the addressable markets that Syntec Optics intends to target do not grow as expected; 4) the loss of any key executives; 5) the loss of any relationships with key suppliers including suppliers abroad; 6) the loss of any relationships with key customers; 7) the inability to protect Syntec Optics' patents and other intellectual property; 8) the failure to successfully execute manufacturing of announced products in a timely manner or at all, or to scale to mass production; 9) costs related to any further business combination; 10) changes in applicable laws or regulations; 11) the possibility that Syntec Optics may be adversely affected by other economic, business and/or competitive factors; 12) Syntec Optics' estimates of its growth and projected financial results for the future and meeting or satisfying the underlying assumptions with respect thereto;

13) the impact of any pandemic, including any mutations or variants thereof and the Russian/Ukrainian or Israeli conflict, and any resulting effect on business and financial conditions; 14) inability to complete any investments or borrowings in connection with any organic or inorganic growth; 15) the potential for events or circumstances that result in Syntec Optics' failure to timely achieve the anticipated benefits of Syntec Optics' customer arrangements; and 16) other risks and uncertainties set forth in the sections entitled "Risk Factors" and "Cautionary Note Regarding Forward-Looking Statements" in prior SEC filings. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Nothing in this press release should be regarded as a representation by any person that the forward-looking statements set forth herein will be achieved or that any of the contemplated results of such forward-looking statements will be achieved. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. Syntec Optics does not give any assurance that Syntec Optics will achieve its expected results. Syntec Optics does not undertake any duty to update these forward-looking statements except as otherwise required by law.

For further information, please contact:

Investor Relations

InvestorRelations@syntecoptics.com

SOURCE: Syntec Optics Holdings, Inc. (Nasdaq: OPTX)

SYNTEC OPTICS HOLDINGS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

SEPTEMBER 30, 2026 AND DECEMBER 31, 2025

 
                                              2026 
                                           (unaudited)      2025 
                                         --------------  ----------- 
ASSETS 
 
Current Assets 
   Cash                                   $  14,357,869  $   358,867 
   Accounts Receivable, net of 
    allowance for expected credit 
    losses of $269,013 and $133,022, 
    respectively                              6,346,861    6,241,768 
   Inventory, net                             7,365,004    7,884,943 
   Prepaid Expenses and Other Assets            393,345      655,827 
                                             ----------   ---------- 
 
Total Current Assets                         28,463,079   15,141,405 
 
Property and Equipment, Net                   9,429,324    9,172,703 
                                             ----------   ---------- 
 
Total Assets                              $  37,892,403  $24,314,108 
                                             ==========   ========== 
 
LIABILITIES AND STOCKHOLDERS' EQUITY 
 
Current Liabilities 
   Accounts Payable                       $   1,677,772  $ 2,691,748 
   Accrued Expenses                           1,023,470      683,397 
   Federal Income Tax Payable                   169,582      169,582 
   Deferred Revenue                             124,044       66,420 
   Line of Credit                                     -    6,763,863 
   Current Maturities of Debt 
    Obligations                                  96,541       93,358 
   Current Maturities of Debt 
    Obligations - Related Party                 481,225      406,495 
   Current Maturities of Finance Lease 
    Obligations                                 376,598      354,499 
                                             ----------   ---------- 
 
Total Current Liabilities                     3,949,232   11,229,362 
 
Long-Term Liabilities 
   Long-Term Debt Obligations                 1,206,977    1,267,043 
   Long-Term Debt Obligations - Related 
    Party                                       835,010      862,237 
   Long-Term Finance Lease Obligations        1,104,431    1,414,611 
                                             ----------   ---------- 
 
Total Long-Term Liabilities                   3,146,418    3,543,891 
                                             ----------   ---------- 
 
Total Liabilities                             7,095,650   14,773,253 
                                             ----------   ---------- 
 
Stockholders' Equity 
   CL A Common Stock, Par value $.0001 
    per share; 121,000,000 authorized; 
    40,279,878 issued and outstanding 
    as of September 30, 2026; 
    36,920,226 issued and outstanding 
    as of December 31, 2025;                      4,028        3,692 
   Additional Paid-In Capital                24,327,789    2,677,181 
   Retained Earnings                          6,464,936    6,859,982 
                                             ----------   ---------- 
 
Total Stockholders' Equity                   30,796,753    9,540,855 
                                             ----------   ---------- 
 
Total Liabilities and Stockholders' 
 Equity                                   $  37,892,403  $24,314,108 
                                             ==========   ========== 
 

SYNTEC OPTICS HOLDINGS, INC.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2026 AND 2025

 
                    September     September     September     September 
                    30, 2026      30, 2025      30, 2026      30, 2025 
                   -----------   -----------   -----------   ----------- 
                      Three Months Ended           Nine Months Ended 
                   -------------------------   ------------------------- 
                    September     September     September     September 
                    30, 2026      30, 2025      30, 2026      30, 2025 
                   -----------   -----------   -----------   ----------- 
 
Net Sales          $ 8,542,554   $ 6,950,220   $23,329,778   $20,578,717 
 
Cost of Goods 
 Sold                6,599,592     6,095,861    18,282,960    15,817,774 
                    ----------    ----------    ----------    ---------- 
 
Gross Profit         1,942,962       854,359     5,046,818     4,760,943 
 
General and 
 Administrative 
 Expenses            1,730,807     2,072,962     5,289,322     5,597,344 
                    ----------    ----------    ----------    ---------- 
 
Income (Loss) 
 from Operations       212,155    (1,218,603)     (242,504)     (836,401) 
 
Other (Expense) 
Income 
   Other Income 
    (Expense)          (18,500)        1,162        49,248         9,124 
   Interest 
    Income             124,008         2,733       203,742        11,766 
   Interest 
    Expense, 
    Including 
    Amortization 
    of Debt 
    Issuance 
    Costs              (71,089)     (214,425)     (405,532)     (624,290) 
                    ----------    ----------    ----------    ---------- 
 
Total Other 
 Income 
 (Expense)              34,419      (210,530)     (152,542)     (603,400) 
                    ----------    ----------    ----------    ---------- 
 
Income (Loss) 
 Before Provision 
 for (Benefit 
 From) Income 
 Taxes                 246,574    (1,429,133)     (395,046)   (1,439,801) 
 
Provision for 
 Income Taxes                -             -             -         9,588 
                    ----------    ----------    ----------    ---------- 
 
Net Income (Loss)  $   246,574   $(1,429,133)  $  (395,046)  $(1,449,389) 
                    ==========    ==========    ==========    ========== 
 
Net Income 
(Loss) per 
Common Share 
   Basic and 
    diluted        $      0.01   $     (0.04)  $     (0.01)  $     (0.04) 
                    ==========    ==========    ==========    ========== 
 
Weighted Average 
Number of Common 
Shares 
Outstanding 
   Basic and 
    diluted         40,279,878    36,920,226    38,820,497    36,920,226 
                    ==========    ==========    ==========    ========== 
 

SYNTEC OPTICS HOLDINGS, INC.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2026 AND 2025

 
                                           2026          2025 
                                        -----------   ----------- 
Cash Flows From Operating Activities 
   Net Loss                             $  (395,046)  $(1,449,389) 
   Adjustments to Reconcile Net Loss 
   to Net Cash Provided By Operating 
   Activities: 
     Depreciation                         1,620,355     2,033,935 
     Amortization of Debt Issuance 
      Costs                                  12,416         7,250 
     Stock-Based Compensation               225,000       225,000 
     Change in Allowance for Expected 
      Credit Losses                         135,991        21,571 
     Change in Reserve for 
      Obsolescence                          (27,053)       (6,499) 
   Changes in Operating Assets and 
   Liabilities: 
     Accounts Receivable                   (241,084)     (103,308) 
     Inventory                              546,992      (962,154) 
     Prepaid Expenses and Other Assets      262,482       351,473 
     Accounts Payable and Accrued 
      Expenses                             (906,965)      395,423 
     Federal Income Tax Receivable                -       179,376 
     Deferred Revenue                        57,624       (16,149) 
                                         ----------    ---------- 
Net Cash Provided By Operating 
 Activities                               1,290,712       676,529 
 
Cash Flows From Investing Activities 
   Purchases of Property and Equipment   (1,643,914)     (643,808) 
                                         ----------    ---------- 
 
Net Cash Used in Investing Activities    (1,643,914)     (643,808) 
 
Cash Flows From Financing Activities 
   Repayments on Line of Credit          (6,763,863)            - 
   Borrowing on Line of Credit                    -       500,000 
   Repayments on Debt Obligations - 
    Related Parties                        (152,497)            - 
   Borrowing on Debt Obligations - 
    Related Parties                         200,000             - 
   Repayments on Debt Obligations           (69,299)     (346,463) 
   Repayments on Finance Lease 
    Obligations                            (288,081)     (207,121) 
   Proceeds from Warrants Exercised              12             - 
   Gross Proceeds from Issuance of 
    Common Stock                         22,999,991             - 
   Payment of Common Stock Issuance 
    Costs                                (1,574,059)            - 
                                         ----------    ---------- 
Net Cash Provided (Used) By Financing 
 Activities                              14,352,204       (53,584) 
                                         ----------    ---------- 
 
Net Increase (Decrease) in Cash          13,999,002       (20,863) 
 
Cash - Beginning                            358,867       598,787 
                                         ----------    ---------- 
 
Cash - Ending                           $14,357,869   $   577,924 
                                         ==========    ========== 
 
Supplemental Cash Flow Disclosures: 
 
Cash Paid for Interest                  $   370,586   $   622,197 
                                         ==========    ========== 
 
Cash Paid for Taxes                     $         -   $         - 
                                         ==========    ========== 
 
Supplemental Disclosures of Non-Cash 
Investing Activities: 
 
Assets Acquired and Included in 
 Accounts Payable                       $   233,062   $     2,050 
Issuance of Common Stock for 
 Stock-Based Compensation               $         7   $        23 
 

NON-GAAP RECONCILIATION OF EBITDA

FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2026 AND 2025

 
                       Three Months Ended         Nine Months Ended 
                    ------------------------   ------------------------ 
                    September     September    September     September 
                     30, 2026     30, 2025      30, 2026     30, 2025 
                    ----------   -----------   ----------   ----------- 
Net Income (Loss)   $  246,574   $(1,429,133)  $ (395,046)  $(1,449,389) 
   Stock-Based 
    Compensation 
    Expense BOD 
    (1)                 75,000       225,000      225,000       225,000 
   Depreciation        548,191       646,508    1,620,355     2,033,935 
   Amortization of 
    Debt Issuance 
    Costs                    -         2,416       12,416         7,250 
   Interest Income    (124,008)       (2,733)    (203,742)      (11,766) 
   Interest 
    Expense             71,089       212,009      393,116       617,040 
   Taxes                     -             -            -         9,588 
Non-Recurring 
Items                                      -                          - 
   Executive 
    Transition 
    (2)                      -       329,972            -       579,161 
   One-time 
    Contract exit 
    costs                    -             -            -        21,063 
   Non-recurring 
    property 
    damage                   -             -       23,211        21,261 
   Incremental 
    auditor 
    transition 
    costs               35,400             -       35,400             - 
                     ---------    ----------    ---------    ---------- 
Adjusted EBITDA     $  852,246   $   (15,961)  $1,710,710   $ 2,053,143 
                     =========    ==========    =========    ========== 
 

In the quarters ended September 30, 2026 and 2025:

 
(1)  Stock-based compensation was issued to independent 
      Board members. 
(2)  A succession plan was required for the transition 
      of the CEO at 2024 year-end. 
 

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment